GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (HAM:SYAB) » Definitions » EBITDA Margin %

Synlab AG (HAM:SYAB) EBITDA Margin % : 21.24% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Synlab AG's EBITDA for the three months ended in Mar. 2024 was €145 Mil. Synlab AG's Revenue for the three months ended in Mar. 2024 was €682 Mil. Therefore, Synlab AG's EBITDA margin for the quarter that ended in Mar. 2024 was 21.24%.


Synlab AG EBITDA Margin % Historical Data

The historical data trend for Synlab AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG EBITDA Margin % Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
24.60 31.85 26.43 23.31

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.97 19.79 42.89 10.80 21.24

Competitive Comparison of Synlab AG's EBITDA Margin %

For the Diagnostics & Research subindustry, Synlab AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synlab AG's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Synlab AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Synlab AG's EBITDA Margin % falls into.



Synlab AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Synlab AG's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=614.311/2635.163
=23.31 %

Synlab AG's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=144.978/682.421
=21.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synlab AG  (HAM:SYAB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Synlab AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Synlab AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synlab AG (HAM:SYAB) Business Description

Traded in Other Exchanges
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (HAM:SYAB) Headlines

No Headlines